Predicting the risk of developing type 2 diabetes in Chinese people who have coronary heart disease and impaired glucose tolerance

<strong>Aims<br></strong> Robust diabetes risk estimates in Asian patients with impaired glucose tolerance (IGT) and coronary heart disease (CHD) are lacking. We developed a Chinese type 2 diabetes risk calculator using Acarbose Cardiovascular Evaluation (ACE) trial data. <br>...

Full description

Bibliographic Details
Main Authors: Xu, S, Scott, CAB, Coleman, RL, Tuomilehto, J, Holman, RR
Format: Journal article
Language:English
Published: Wiley 2021
_version_ 1826309278011490304
author Xu, S
Scott, CAB
Coleman, RL
Tuomilehto, J
Holman, RR
author_facet Xu, S
Scott, CAB
Coleman, RL
Tuomilehto, J
Holman, RR
author_sort Xu, S
collection OXFORD
description <strong>Aims<br></strong> Robust diabetes risk estimates in Asian patients with impaired glucose tolerance (IGT) and coronary heart disease (CHD) are lacking. We developed a Chinese type 2 diabetes risk calculator using Acarbose Cardiovascular Evaluation (ACE) trial data. <br><strong> Methods<br></strong> There were 3105 placebo-treated ACE participants with requisite data for model development. Clinically relevant variables, and those showing nominal univariate association with new-onset diabetes (P < .10), were entered into BASIC (clinical variables only), EXTENDED (clinical variables plus routinely available laboratory results), and FULL (all candidate variables) logistic regression models. External validation was performed using the Luzhou prospective cohort of 1088 Chinese patients with IGT. <br><strong> Results<br></strong> Over median 5.0 years, 493 (15.9%) ACE participants developed diabetes. Lower age, higher body mass index, and use of corticosteroids or thiazide diuretics were associated with higher diabetes risk. C-statistics for the BASIC (using these variables), EXTENDED (adding male sex, fasting plasma glucose, 2-hour glucose, and HbA1c), and FULL models were 0.610, 0.757, and 0.761 respectively. The EXTENDED model predicted a lower 13.9% 5-year diabetes risk in the Luzhou cohort than observed (35.2%, 95% confidence interval 31.3%-39.5%, C-statistic 0.643). <br><strong> Conclusion<br></strong> A risk prediction model using routinely available clinical variables can be used to estimate diabetes risk in Chinese people with CHD and IGT.
first_indexed 2024-03-07T07:33:19Z
format Journal article
id oxford-uuid:5eedd724-6d8f-48b5-a3fb-b7c58811aab4
institution University of Oxford
language English
last_indexed 2024-03-07T07:33:19Z
publishDate 2021
publisher Wiley
record_format dspace
spelling oxford-uuid:5eedd724-6d8f-48b5-a3fb-b7c58811aab42023-02-10T13:40:30ZPredicting the risk of developing type 2 diabetes in Chinese people who have coronary heart disease and impaired glucose toleranceJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:5eedd724-6d8f-48b5-a3fb-b7c58811aab4EnglishSymplectic ElementsWiley2021Xu, SScott, CABColeman, RLTuomilehto, JHolman, RR<strong>Aims<br></strong> Robust diabetes risk estimates in Asian patients with impaired glucose tolerance (IGT) and coronary heart disease (CHD) are lacking. We developed a Chinese type 2 diabetes risk calculator using Acarbose Cardiovascular Evaluation (ACE) trial data. <br><strong> Methods<br></strong> There were 3105 placebo-treated ACE participants with requisite data for model development. Clinically relevant variables, and those showing nominal univariate association with new-onset diabetes (P < .10), were entered into BASIC (clinical variables only), EXTENDED (clinical variables plus routinely available laboratory results), and FULL (all candidate variables) logistic regression models. External validation was performed using the Luzhou prospective cohort of 1088 Chinese patients with IGT. <br><strong> Results<br></strong> Over median 5.0 years, 493 (15.9%) ACE participants developed diabetes. Lower age, higher body mass index, and use of corticosteroids or thiazide diuretics were associated with higher diabetes risk. C-statistics for the BASIC (using these variables), EXTENDED (adding male sex, fasting plasma glucose, 2-hour glucose, and HbA1c), and FULL models were 0.610, 0.757, and 0.761 respectively. The EXTENDED model predicted a lower 13.9% 5-year diabetes risk in the Luzhou cohort than observed (35.2%, 95% confidence interval 31.3%-39.5%, C-statistic 0.643). <br><strong> Conclusion<br></strong> A risk prediction model using routinely available clinical variables can be used to estimate diabetes risk in Chinese people with CHD and IGT.
spellingShingle Xu, S
Scott, CAB
Coleman, RL
Tuomilehto, J
Holman, RR
Predicting the risk of developing type 2 diabetes in Chinese people who have coronary heart disease and impaired glucose tolerance
title Predicting the risk of developing type 2 diabetes in Chinese people who have coronary heart disease and impaired glucose tolerance
title_full Predicting the risk of developing type 2 diabetes in Chinese people who have coronary heart disease and impaired glucose tolerance
title_fullStr Predicting the risk of developing type 2 diabetes in Chinese people who have coronary heart disease and impaired glucose tolerance
title_full_unstemmed Predicting the risk of developing type 2 diabetes in Chinese people who have coronary heart disease and impaired glucose tolerance
title_short Predicting the risk of developing type 2 diabetes in Chinese people who have coronary heart disease and impaired glucose tolerance
title_sort predicting the risk of developing type 2 diabetes in chinese people who have coronary heart disease and impaired glucose tolerance
work_keys_str_mv AT xus predictingtheriskofdevelopingtype2diabetesinchinesepeoplewhohavecoronaryheartdiseaseandimpairedglucosetolerance
AT scottcab predictingtheriskofdevelopingtype2diabetesinchinesepeoplewhohavecoronaryheartdiseaseandimpairedglucosetolerance
AT colemanrl predictingtheriskofdevelopingtype2diabetesinchinesepeoplewhohavecoronaryheartdiseaseandimpairedglucosetolerance
AT tuomilehtoj predictingtheriskofdevelopingtype2diabetesinchinesepeoplewhohavecoronaryheartdiseaseandimpairedglucosetolerance
AT holmanrr predictingtheriskofdevelopingtype2diabetesinchinesepeoplewhohavecoronaryheartdiseaseandimpairedglucosetolerance